M H May

1.6k total citations
24 papers, 1.3k citations indexed

About

M H May is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, M H May has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in M H May's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). M H May is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). M H May collaborates with scholars based in United States. M H May's co-authors include Alfred J. Crowle, E Ross, Rolf Dahl, George S. Douvas, Charles E. Shields, H. Franklin Bunn, Walter Kocholaty, John A. Sbarbaro, A Y Tsang and A. E. Vatter and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Allergy and Clinical Immunology and Journal of Clinical Microbiology.

In The Last Decade

M H May

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M H May United States 16 630 563 299 225 122 24 1.3k
Zdeňek Zı́dek Czechia 21 238 0.4× 313 0.6× 512 1.7× 308 1.4× 167 1.4× 112 1.5k
Patricia A. Masso‐Welch United States 15 366 0.6× 348 0.6× 499 1.7× 536 2.4× 121 1.0× 27 1.6k
Gerd Michel Germany 23 374 0.6× 822 1.5× 344 1.2× 91 0.4× 106 0.9× 61 1.7k
Ling Wang China 25 575 0.9× 328 0.6× 432 1.4× 110 0.5× 73 0.6× 96 1.8k
J. Symoens Belgium 16 197 0.3× 281 0.5× 145 0.5× 163 0.7× 66 0.5× 45 1.2k
Makoto Matsukura Japan 22 518 0.8× 304 0.5× 1.1k 3.6× 226 1.0× 61 0.5× 78 2.2k
Luiz Antônio Rodrigues de Freitas Brazil 26 143 0.2× 902 1.6× 278 0.9× 224 1.0× 105 0.9× 97 1.8k
Mahboob Qureshi Japan 23 483 0.8× 925 1.6× 367 1.2× 575 2.6× 157 1.3× 38 1.6k
Manuel Conde Spain 18 152 0.2× 286 0.5× 430 1.4× 202 0.9× 162 1.3× 49 1.3k
Joel Bowman United States 9 676 1.1× 646 1.1× 499 1.7× 142 0.6× 86 0.7× 10 1.7k

Countries citing papers authored by M H May

Since Specialization
Citations

This map shows the geographic impact of M H May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M H May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M H May more than expected).

Fields of papers citing papers by M H May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M H May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M H May. The network helps show where M H May may publish in the future.

Co-authorship network of co-authors of M H May

This figure shows the co-authorship network connecting the top 25 collaborators of M H May. A scholar is included among the top collaborators of M H May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M H May. M H May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Douvas, George S., M H May, Annita Kolnagou, & George J. Kontoghiorghes. (2011). Effects on Mycobacterium avium Replication in Normal Human Macrophages by Deferiprone (L1) and Other Iron Chelators. Arzneimittelforschung. 52(1). 45–52. 1 indexed citations
2.
Douvas, George S., et al.. (1994). Hypertriglyceridemic Serum, Very Low Density Lipoprotein, And Iron Enhance Mycobacterium Avium Replication In Human Macrophages. The Journal of Infectious Diseases. 170(5). 1248–1255. 8 indexed citations
3.
Douvas, George S., M H May, & Alfred J. Crowle. (1993). Transferrin, Iron, and Serum Lipids Enhance or Inhibit Mycobacterium avium Replication in Human Macrophages. The Journal of Infectious Diseases. 167(4). 857–857. 36 indexed citations
4.
Crowle, Alfred J., George S. Douvas, & M H May. (1992). Chlorpromazine: A Drug Potentially Useful for Treating Mycobacterial Infections. Chemotherapy. 38(6). 410–419. 108 indexed citations
6.
Douvas, George S., M H May, E Ross, & Alfred J. Crowle. (1992). Characterization of inhibition of Mycobacterium avium replication in macrophages by normal human serum. Infection and Immunity. 60(2). 345–352. 6 indexed citations
7.
Crowle, Alfred J., Rolf Dahl, E Ross, & M H May. (1991). Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infection and Immunity. 59(5). 1823–1831. 250 indexed citations
8.
May, M H, et al.. (1990). Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sciences. 46(22). 1601–1609. 104 indexed citations
9.
10.
Crowle, Alfred J., Max Salfinger, & M H May. (1989). 1,25(OH) 2 -Vitamin D 3 Synergizes with Pyrazinamide To Kill Tubercle Bacilli in Cultured Human Macrophages. American Review of Respiratory Disease. 139(2). 549–552. 18 indexed citations
11.
Crowle, Alfred J., Nancy Elkins, & M H May. (1988). Effectiveness of Ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium , and Rifampin against M. tuberculosis in Cultured Human Macrophages. American Review of Respiratory Disease. 137(5). 1141–1146. 51 indexed citations
12.
Crowle, Alfred J., John A. Sbarbaro, & M H May. (1988). Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages. Tubercle. 69(1). 15–25. 17 indexed citations
13.
Crowle, Alfred J., E Ross, & M H May. (1987). Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infection and Immunity. 55(12). 2945–2950. 191 indexed citations
14.
Crowle, Alfred J., John A. Sbarbaro, & M H May. (1986). Inhibition by Pyrazinamide of Tubercle Bacilli within Cultured Human Macrophages 1– 3. American Review of Respiratory Disease. 134(5). 1052–1055. 43 indexed citations
15.
Crowle, Alfred J., John A. Sbarbaro, Franklyn N. Judson, George S. Douvas, & M H May. (1984). Inhibition by streptomycin of tubercle bacilli within cultured human macrophages.. PubMed. 130(5). 839–44. 40 indexed citations
16.
Crowle, Alfred J., George S. Douvas, & M H May. (1983). [Cellular and molecular nature of tubercular immunity in man].. PubMed. 58(1). 75–84. 3 indexed citations
17.
Crowle, Alfred J. & M H May. (1983). Replication of lyophilized and cultured BCG in human macrophages.. PubMed. 128(4). 673–9. 12 indexed citations
18.
Crowle, Alfred J. & M H May. (1982). Suppression of tuberculoimmunity in mice by Evans blue dye. Infection and Immunity. 38(3). 932–937. 1 indexed citations
19.
Crowle, Alfred J. & M H May. (1978). A hanging drop macrophage function test.. PubMed. 24(2). 169–85. 5 indexed citations
20.
Crowle, Alfred J., et al.. (1977). Induction of delayed hypersensitivity to protein antigens in mice without Freund adjuvants. Journal of Allergy and Clinical Immunology. 60(1). 14–26. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026